- Home
- UNCY vs ZENV Comparison
UNCY vs ZENV Comparison
Compare UNCY & ZENV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UNCY
- ZENV
- Stock Information
- Founded
- UNCY 2016
- ZENV 2005
- Country
- UNCY United States
- ZENV Brazil
- Employees
- UNCY N/A
- ZENV N/A
- Industry
- UNCY Biotechnology: Pharmaceutical Preparations
- ZENV Computer Software: Prepackaged Software
- Sector
- UNCY Health Care
- ZENV Technology
- Exchange
- UNCY Nasdaq
- ZENV Nasdaq
- Market Cap
- UNCY 74.2M
- ZENV 79.7M
- IPO Year
- UNCY 2021
- ZENV 2021
- Fundamental
- Price
- UNCY $4.36
- ZENV $1.51
- Analyst Decision
- UNCY Strong Buy
- ZENV
- Analyst Count
- UNCY 4
- ZENV 0
- Target Price
- UNCY $63.75
- ZENV N/A
- AVG Volume (30 Days)
- UNCY 483.3K
- ZENV 35.8K
- Earning Date
- UNCY 08-14-2025
- ZENV 09-10-2025
- Dividend Yield
- UNCY N/A
- ZENV N/A
- EPS Growth
- UNCY N/A
- ZENV N/A
- EPS
- UNCY N/A
- ZENV N/A
- Revenue
- UNCY N/A
- ZENV $181,911,572.00
- Revenue This Year
- UNCY N/A
- ZENV $6.49
- Revenue Next Year
- UNCY $3,131.28
- ZENV $3.82
- P/E Ratio
- UNCY N/A
- ZENV N/A
- Revenue Growth
- UNCY N/A
- ZENV 23.99
- 52 Week Low
- UNCY $3.24
- ZENV $1.02
- 52 Week High
- UNCY $11.00
- ZENV $3.03
- Technical
- Relative Strength Index (RSI)
- UNCY 49.39
- ZENV 44.73
- Support Level
- UNCY $4.15
- ZENV $1.53
- Resistance Level
- UNCY $4.35
- ZENV $1.64
- Average True Range (ATR)
- UNCY 0.24
- ZENV 0.09
- MACD
- UNCY 0.05
- ZENV -0.01
- Stochastic Oscillator
- UNCY 53.76
- ZENV 36.36
About UNCY Unicycive Therapeutics Inc.
Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's manufactures drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury. Company's pipeline comprised of two product candidates: Oxylanthanum Carbonate and UNI-494.
About ZENV Zenvia Inc.
Zenvia Inc provides a platform that enables companies to create journeys for their end customers across a variety of channels. The company operates in two reportable segments namely CPaaS and SaaS. It has a geographic presence in Brazil, the USA, Argentina, Mexico, and Others. The company generates the majority of its revenue from Brazil.